| Old Articles: <Older 31271-31280 Newer> |
 |
The Motley Fool July 25, 2008 Brian Orelli |
Generic Heartburn at Wyeth Revenue from its heartburn drug Protonix dropped 59% year over year after Teva Pharmaceuticals and Sun Pharmaceuticals launched their generic versions of the drug.  |
The Motley Fool July 25, 2008 Christopher Barker |
Bucy in the Mine With Diamonds Mining equipment specialist Bucyrus digs up another strong quarter.  |
The Motley Fool July 25, 2008 Toby Shute |
Still Sweet on Suncor The oil sands sultan works towards its goal of 550,000 barrels of daily production by 2012.  |
The Motley Fool July 25, 2008 Tim Beyers |
Fool Blog: Wall Street Can Be Trusted Should investment banks once again be able to offer semi-legit research to IPO clients so as to grease the market for soon-to-be offered shares?  |
The Motley Fool July 25, 2008 Dan Dzombak |
3 Stocks Hitting High Notes These stocks are bucking the trend.  |
The Motley Fool July 25, 2008 Alex Dumortier |
National City Talks the Talk, Walks the Walk National City -- the worst performing stock in the KBW Bank Index -- makes a good impression with its quarterly results.  |
The Motley Fool July 25, 2008 Christopher Barker |
This Week in Commodities Market news: Unloading commodities like they're mortgage-backed securities... natural gas has fallen more than twice the distance that oil has... Volatility for coal mining and steel...  |
The Motley Fool July 25, 2008 Alyce Lomax |
The Job That Keeps Paying Abercrombie's departing CFO gets a heck of a deal.  |
The Motley Fool July 25, 2008 David Lee Smith |
Hail the King of Coal Amid exploding demand, Peabody Energy, the king of coal companies, leads the parade in the size of its earnings surprise and its upside potential.  |
The Motley Fool July 25, 2008 Toby Shute |
No Peak in Sight for Potash There's simply much more cash to be made in potash. The supply constraints are just that substantial.  |
| <Older 31271-31280 Newer> Return to current articles. |